Why Is JoinJosie the Best for Injectables and Creams?

Women on compounded GLP-1 shots often run into dose shortages or unpredictable refills because standard clinics treat these medicines as add-ons. Josie treats them as part of one provider-led plan that already includes HRT creams and maintenance dosing.

By the end of this article you will know which injectables and creams Josie offers, how the full-dose and micro-dose options differ from each other, and how pricing and safety checks compare across the plans listed in the outline.

What Is Josie?

Josie is a provider-led telehealth service that delivers integrated care for women experiencing perimenopause and menopause. The platform combines hormone replacement therapy, GLP-1 weight management, and weight maintenance into unified care paths. Every prescription requires review by a licensed provider before medications are approved.

Medications ship from licensed U.S. pharmacies to patients across the country. Providers hold licenses in all 50 states, which ensures continuity of care regardless of location. This structure addresses the needs of women in midlife who have historically received fragmented treatment options.

The mission focuses on bringing hormone replacement therapy and GLP-1 weight management together under one roof. Patients receive coordinated care rather than separate prescriptions from multiple sources. All care paths follow the same provider oversight requirements.

Why Josie Is the Best Choice for Injectables and Creams

Josie stands out by integrating weight-management injectables with menopause-focused hormone creams under one provider-led model. This single-care-path approach means patients receive coordinated treatment for both metabolic and hormonal needs. The result is a streamlined experience that avoids the usual fragmentation of care.

Every prescription undergoes provider review before approval. Licensed clinicians evaluate each case individually rather than relying on automated approvals. This step protects patient safety and ensures dosing matches clinical needs.

Josie eliminates auto-billing entirely. Patients can pause or cancel at any time without hidden fees or surprise charges. This flexibility respects changing health priorities and budgets.

The platform has issued over 5,000 prescriptions to more than 5,000 members. Members report average weight loss of 10-12% with semaglutide and 12-15% with tirzepatide within the first six months. These outcomes reflect the effectiveness of the combined care model.

All medications come from U.S. certified pharmacies and undergo batch testing for potency, sterility, pH, and endotoxins. Fast and free shipping keeps treatment on schedule without extra logistics.

Josie earned the #1 Menopause GLP-1 Provider ranking from Global Women Connected and maintains a 4.9 average rating. The combination of personalized care, consistent oversight, and transparent billing policies supports these results.

Provider-Led Telehealth Care for Perimenopause and Menopause

Josie delivers perimenopause and menopause care through board-certified physicians who review every prescription before dispensing. This structure places medical expertise at the center of treatment decisions rather than leaving patients to navigate options alone.

Dr. Ana Lisa Carr serves as Medical Director. She is a Board-Certified Family Medicine Physician with board eligibility in Addiction Medicine and Obesity Medicine. She brings over 15 years of clinical experience and holds active licenses in all 50 states.

Dr. Carr earned her undergraduate degree from the University of Miami and her medical degree from St. George's University. She completed a Physicians Executive MBA from Auburn University. Her residency training took place at the University of Virginia and WSU Boonshoft School of Medicine, where she served as Chief Resident. She received advanced Addiction Medicine training at Vanderbilt University School of Medicine. She is fluent in English and Spanish.

The multi-state licensing model allows Dr. Carr to oversee care across the country. Every GLP-1 or HRT prescription undergoes a one-to-one provider review before approval. This step ensures each treatment plan matches the patient's medical profile.

Patients receive care from licensed practitioners who evaluate symptoms, review health history, and confirm appropriate dosing. The process supports safe prescribing of medical-grade injectables and creams. Patients benefit from consistent oversight, dosage accuracy, and follow-up care throughout treatment.

Full-Dose GLP-1 Injectables and Creams: Weight Management

Josie's weight-management pathway supplies both compounded and branded GLP-1 options in injectable and oral forms.

Provider-led telehealth care paths combine sterile compounding protocols with licensed pharmacy fulfillment to support safe medication delivery.

Dosage accuracy requires ongoing provider oversight throughout each care path. Check-ins allow adjustments based on individual response and tolerance.

Compounded GLP-1 medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before marketing.

Patients who complete their weight-management goals may transition to a microdose maintenance protocol. This structured step-down approach supports long-term progress.

Compounded Semaglutide Injection

Compounded Semaglutide Injection is supplied in pre-filled syringes with exact micro-graduated dosing.

The injection protocol follows a weekly subcutaneous schedule. Sterile handling procedures ensure each dose maintains integrity from pharmacy to patient.

Compounded medications are not FDA-approved. Josie does not manufacture compounded medications. Licensed compounding pharmacies prepare each syringe under controlled conditions.

Provider review occurs before any prescription is issued. Follow-up support addresses questions about administration technique and timing.

Compounded Tirzepatide Injection

Compounded Tirzepatide Injection is titrated in 2.5 mg increments to match individual GLP-1 receptor sensitivity.

Stepwise titration allows gradual dose increases while monitoring tolerance. Sterile cold-chain shipping preserves medication potency during transit.

Compounded agents lack FDA approval. Provider-guided dose adjustments occur based on patient feedback and clinical indicators at each follow-up interval.

Weight Management pricing starts as low as $194 per month. The process includes online intake, provider review, and pharmacy shipment when prescribed.

Branded Options: Ozempic(r), Wegovy(r), Zepbound(r)

Josie also offers the brand-name GLP-1 injectables Ozempic(r), Wegovy(r), and Zepbound(r) for patients who prefer FDA-approved formulations.

Authenticity is guaranteed through licensed U.S. pharmacies. Monthly pricing tiers include Ozempic(r) as low as $1299, Wegovy(r) as low as $1199, and Zepbound(r) as low as $1099.

Provider oversight remains consistent across both compounded and branded paths. Patients receive the same review process and follow-up support regardless of formulation choice.

Weight Management care paths include ongoing provider support for check-ins. Dose adjustments are available when clinically appropriate.

Microdose GLP-1 Maintenance Plan

After reaching goal weight, Josie transitions patients to a micro-dose GLP-1 plan that preserves results with lower monthly dosing. The Weight Maintenance subscription costs $189 per month and helps sustain progress through a carefully managed maintenance schedule.

Patients typically receive injections at intervals determined by their provider. Doses remain lower than active weight loss amounts yet sufficient to support metabolic balance and appetite regulation.

Regular provider check-ins allow dose adjustments based on individual response. These reviews help prevent weight regain by fine-tuning the amount needed for each person.

Providers monitor progress and make changes as needed. This approach keeps treatment responsive to patient needs while maintaining results over time.

The micro-dose plan integrates with Josie's broader weight management offerings. Patients who started with Weight Management GLP-1 at as low as $194 per month can transition smoothly to the $189 maintenance rate.

No membership fees apply beyond the monthly subscription. Patients can cancel anytime without penalties or hidden costs. This flexibility supports long-term adherence to the maintenance protocol.

Hormone Replacement Therapy (HRT) Creams

Josie compounds individualized HRT creams that deliver bioidentical estradiol and progesterone through daily topical application.

The formulation process begins with lab results that guide each cream's hormone ratios. A licensed provider reviews these results and specifies exact estradiol and progesterone concentrations for the compounding pharmacy.

Customized dosing eliminates the need for multiple products. Patients receive one cream that matches their current hormone profile rather than adjusting separate prescriptions over time.

Application follows a simple once-daily routine. Users apply the measured amount at the same time each day, which helps maintain steady hormone levels without daily fluctuations.

Provider oversight continues after the initial prescription. Regular check-ins allow dose adjustments when follow-up labs show the need for changes in estrogen or progesterone strength.

The provider-led telehealth model keeps the entire process connected. Online intake leads to licensed review, and any prescribed cream ships directly from a compounding pharmacy.

Pricing and Plans for Injectables and Creams

Josie publishes transparent monthly fees for every injectable and cream option, starting at $89 for HRT.

Patients can choose from four clear price points without surprise charges. Full-dose GLP-1 starts at $194 each month, while micro-dose maintenance sits at $189 monthly for those who have reached their goals.

Hormone replacement therapy runs as low as $89 per month, providing an accessible entry point for clients seeking balance. Branded GLP-1 medications such as Ozempic, Wegovy, and Zepbound range from $1,099 to $1,299 monthly.

Every plan avoids hidden fees or automatic renewal penalties. No membership fees apply, and clients can cancel at any time without financial penalties.

Discounts become available through the Find My Path quiz, offering up to $100 off the first Weight Management purchase, $50 off Weight Maintenance, and $75 off HRT.

These straightforward rates help patients select the right treatment level without guessing at final costs. The structure supports both initial therapy and ongoing maintenance with clear monthly expectations.

Trust Signals: Track Record and Safety

Josie has served more than 5,000 members and written over 5,000 prescriptions. This record stems from a provider-led model that places every prescription under licensed review before any medication reaches the patient.

Every prescription undergoes provider review. This step confirms that each injectable and cream aligns with the member's documented needs and medical history. The process eliminates guesswork and keeps dosing decisions in the hands of qualified professionals.

Medications originate only from licensed U.S. pharmacies. Each batch undergoes testing for potency, sterility, pH, and endotoxins. These checks ensure that injectables and creams meet the same standards used for hospital-grade products.

Personalized care paths focus on perimenopause and menopause. This targeted approach matches treatment selection to the specific symptoms members report, rather than applying generic protocols across the board.

Fast and free shipping keeps treatment timelines consistent. Members receive their medications directly at home, which supports adherence and reduces the chance of missed doses or treatment gaps.

The average member rating of 4.9 reflects satisfaction with both the safety protocols and the outcomes. This feedback comes from real experiences with injectables and creams that follow the same verification steps every time.

Who Should Use Josie for Injectables and Creams

Josie serves women in perimenopause or menopause who need coordinated hormone and weight-management support. These stages often bring vasomotor symptoms, metabolic shifts, and weight gain that may benefit from targeted care.

Women aged 40-plus facing these changes may find Josie helpful for addressing both hormone needs and weight-management goals. The service focuses on this specific group rather than a broader audience.

Eligibility for injectables and creams begins with an initial provider consultation. This step determines whether a patient is a suitable candidate and allows for a personalized treatment plan based on individual health factors.

Patients receive guidance from licensed practitioners who assess medical history, current symptoms, and treatment goals. The consultation ensures that any recommended injectables or creams align with the patient's overall care plan.

Josie targets those seeking integrated support during perimenopause and menopause rather than isolated cosmetic procedures. This approach may be particularly relevant for women managing multiple symptoms at once.